Evidence map›Paper›PMID 40276801›Full record

ReviewFrontiers in chemistry2025

Micro-nano robots for treatment of eye diseases.

Haocheng Wang, Jingxue Sun, Xiaona Zhang, Yingjie Zhou, Yaguang Zhang, Yanan Ni, Minnan Wang, Yanmeizhi Wu, Lulu Sun, Xiaoyu Zhao and 1 more

Abstract readReview
In one paragraph

Review in Frontiers in chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Therapeutic peptides and proteins: Status and developments in drug delivery.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Haocheng Wang *State Key Laboratory of Robotics and System, Harbin Institute of Technology, Harbin, China.
Jingxue Sun *Department of Endocrinology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Xiaona Zhang *Department of Endocrinology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Yingjie ZhouDepartment of Anesthesiology, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Yaguang ZhangDepartment of Endocrinology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Yanan NiDepartment of Endocrinology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Minnan WangDepartment of Endocrinology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Yanmeizhi WuDepartment of Endocrinology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Lulu SunDepartment of Endocrinology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Xiaoyu ZhaoDepartment of Endocrinology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Hong QiaoDepartment of Endocrinology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, micro-nano robots have found extensive applications in the field of medicine. Among these, micro-nano robots demonstrate significant potential for the treatment of eye diseases. Micro-nano robots can penetrate eye tissue barriers to directly target the posterior segment of the eye for precise drug delivery, enabling non-invasive or minimally invasive treatment. This review explores the primary fabrication methods and propulsion mechanisms of various micro-nano robots, and their applications in treating various eye conditions, offering inspiration and guidance for advancing the use of micro-nanorobots in ophthalmic therapies.

Indexed as

applicationsdrug deliveryeye diseasesmicro-nano robotson-target drug delivery

Identifiers

PMID40276801
PMCPMC12018383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.